Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Work In Process (2016 - 2019)

Tandem Diabetes Care (TNDM) has disclosed Work In Process for 6 consecutive years, with $3.6 million as the latest value for Q1 2019.

  • For the quarter ending Q1 2019, Work In Process fell 5.34% year-over-year to $3.6 million, compared with a TTM value of $3.6 million through Mar 2019, down 5.34%, and an annual FY2018 reading of $2.7 million, down 28.91% over the prior year.
  • Work In Process was $3.6 million for Q1 2019 at Tandem Diabetes Care, up from $2.7 million in the prior quarter.
  • Across five years, Work In Process topped out at $6.6 million in Q2 2017 and bottomed at $2.6 million in Q2 2015.
  • Average Work In Process over 5 years is $4.2 million, with a median of $3.8 million recorded in 2017.
  • The sharpest move saw Work In Process skyrocketed 74.78% in 2016, then tumbled 52.51% in 2018.
  • Year by year, Work In Process stood at $3.4 million in 2015, then grew by 29.49% to $4.4 million in 2016, then dropped by 13.27% to $3.8 million in 2017, then decreased by 28.91% to $2.7 million in 2018, then skyrocketed by 31.37% to $3.6 million in 2019.
  • Business Quant data shows Work In Process for TNDM at $3.6 million in Q1 2019, $2.7 million in Q4 2018, and $4.5 million in Q3 2018.